REDANA Trademark

Trademark Overview

On Thursday, September 3, 2009, a trademark application was filed for REDANA with the United States Patent and Trademark Office. The USPTO has given the REDANA trademark a serial number of 77819166. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 6, 2013. This trademark is owned by Glaxo Group Limited. The REDANA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; vaccines
redana

General Information

Serial Number77819166
Word MarkREDANA
Filing DateThursday, September 3, 2009
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 6, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 12, 2010

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; vaccines
Translation of Words in MarkThe wording "REDANA" has no meaning other than trademark significance.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 17, 2009
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB6ONN
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB6ONN
GB

Trademark Events

Event DateEvent Description
Monday, May 6, 2013ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, May 6, 2013ABANDONMENT - NO USE STATEMENT FILED
Tuesday, September 25, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 24, 2012EXTENSION 5 GRANTED
Thursday, September 20, 2012EXTENSION 5 FILED
Thursday, September 20, 2012TEAS EXTENSION RECEIVED
Wednesday, February 22, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 21, 2012EXTENSION 4 GRANTED
Wednesday, February 15, 2012EXTENSION 4 FILED
Wednesday, February 15, 2012TEAS EXTENSION RECEIVED
Tuesday, August 30, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 29, 2011EXTENSION 3 GRANTED
Wednesday, August 24, 2011EXTENSION 3 FILED
Wednesday, August 24, 2011TEAS EXTENSION RECEIVED
Friday, March 4, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 3, 2011EXTENSION 2 GRANTED
Thursday, February 17, 2011EXTENSION 2 FILED
Thursday, March 3, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, February 17, 2011TEAS EXTENSION RECEIVED
Saturday, September 18, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 16, 2010EXTENSION 1 GRANTED
Thursday, September 16, 2010EXTENSION 1 FILED
Thursday, September 16, 2010TEAS EXTENSION RECEIVED
Wednesday, May 12, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 6, 2010NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 12, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 12, 2010PUBLISHED FOR OPPOSITION
Monday, December 7, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, December 7, 2009ASSIGNED TO LIE
Wednesday, November 18, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 17, 2009EXAMINER'S AMENDMENT ENTERED
Tuesday, November 17, 2009NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, November 17, 2009EXAMINERS AMENDMENT E-MAILED
Tuesday, November 17, 2009EXAMINERS AMENDMENT -WRITTEN
Friday, November 13, 2009ASSIGNED TO EXAMINER
Thursday, October 29, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 8, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, September 7, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords

redana pharmaceutical treatment substances disorders preparations diseases hormonal neurological gastrointestinal ophthalmic